Jan 25 (Reuters) - MITHRA PHARMACEUTICALS SA:
* ‍MITHRA ANNOUNCES LAST SUBJECT COMPLETES DONESTA® PHASE II STUDY​
* ‍PHASE II STUDY ON TRACK TO YIELD TOP LINE DATA LATE Q1 2018​
* ‍260 WOMEN RECRUITED, OVER 200 COMPLETED AT LEAST 12 WEEKS OF TREATMENT IN PHASE II STUDY​
* ‍12-WEEK DATA GENERATED FOR ADDITIONAL 15% OF SUBJECTS TO IMPROVE ROBUSTNESS OF ANALYSIS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 